News
While the drugs have grown in popularity among doctors and patients, they are generally too expensive for most people to ...
Novo Nordisk has launched its hugely popular weight-loss drug Wegovy in Thailand, an executive of the Danish drugmaker's ...
Novo Nordisk has launched its popular weight-loss drug Wegovy in Thailand, marking its first entry into the Southeast Asian ...
All these drugs are very effective and they’ve become a game changer for people who need to lose weight. Get on the drug, eat ...
The Trump administration this month scrapped a Biden-era proposal that would have required state Medicaid programs and allowed federal Medicare to pay for some GLP-1s for obesity treatment. Instead, ...
Weight loss injections can be useful aids for people who are struggling to shed unwanted pounds. GLP-1 agonist jabs, like ...
3h
Health and Me on MSNNovo Nordisk Launches Weight Loss Drug Wegovy In ThailandWegovy's launch in Thaliand comes nearly a month after Eli Lilly launched its obesity management drug Mounjaro in India at ...
9h
Stocktwits on MSNNovo Nordisk’s Weight-Loss Drug Wegovy Launched In Thailand, Marks Entry Into Southeast AsiaNovo Nordisk (NVO) has launched its weight-loss drug Wegovy in Thailand, Reuters reported on Monday, citing an executive of ...
A PRESENTER has candidly opened up on her “absolutely horrendous” experience while using Mounjaro. Danielle Mason, an ...
A Howard County man is suing Novo Nordisk, alleging Ozempic caused him to go blind after using the drug to treat diabetes. He seeks damages in court.
Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for cardiometabolic diseases and GI oncological indications announced today that it ...
President Donald Trump is under pressure to decide how widely available anti-obesity drugs should be and whether Medicare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results